Legend Biotech (STU:9LB) Net Interest Margin (Bank Only) %


STU:9LB Legend Biotech Corp STU:9LB
73 GF Score
Price €26.20
GF Value €86.85
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Legend Biotech Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:9LB
73GF Score
Legend Biotech Corp STU:9LB
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Legend Biotech (STU:9LB) Overvalued in 2026?

Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued. The current stock price of €26.20 is trading 69.8% below its estimated GF Value™ of €86.85. GuruFocus considers Legend Biotech to be Possible Value Trap.

Key valuation signals for STU:9LB:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €86.85 vs. price of €26.20 (69.8% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the STU:9LB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Legend Biotech Business Description

Other Exchanges LEGN:USA
Address 2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
73GF Score

Get the complete analysis for STU:9LB

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.20
Price
€86.85
GF Value